Advanced Biomedical Technologies, Inc.
Advanced Biomedical Technologies, Inc. (ABMT) Revenue
Annual & quarterly revenue history · segment & region breakdown
ABMT · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAdvanced Biomedical Technologies, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 58.30% year-over-year from $0.00B in FY2022.
Revenue trend
2022 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-10-31 | $0.00B | +$0.00B | +58.30% |
| 2021-10-31 | $0.00B | +$0.00B | +38.52% |
| 2020-10-31 | $0.00B | +$0.00B | +960.20% |
| 2019-10-31 | $0.00B | +$0.00B | — |
| 2018-10-31 | $0.00B | +$0.00B | — |
| 2017-10-31 | $0.00B | +$0.00B | — |
| 2016-10-31 | $0.00B | +$0.00B | — |
| 2015-10-31 | $0.00B | +$0.00B | — |
| 2014-10-31 | $0.00B | +$0.00B | — |
| 2013-10-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Advanced Biomedical Technologies, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Advanced Biomedical Technologies, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Advanced Biomedical Technologies, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ABMT revenue · 4 questionsABMT's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 58.30% year-over-year from $0.00B in FY2022.
▸ Source: FMP · Advanced Biomedical Technologies, Inc. SEC filings · GAAP · Advanced Biomedical Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026